Repotrectinib

Records for this ingredient, by country (identity only).

ATC L01EX28 · 7 markets · 14 records

Repotrectinib 7 markets · 14 records Forms
Filters

AU 5 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 40 mgcapsuleAugtyroAUGTYRO repotrectinib 40 mg capsule bottle also in US·JP·TW unknown
  • 160 mgcapsuleAugtyroAUGTYRO repotrectinib 160 mg capsule blister pack also in US·JP unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.